Online information & support
Retina UK has a number of online support resources which we offer via social media.
Search results
Retina UK has a number of online support resources which we offer via social media.
The aim of the site is to increase the level of awareness and understanding of genetic testing and genetic counselling among people living with inherited retinal dystrophies, empowering them to make fully informed decisions about their lives, healthcare and family planning.
Our Board of Trustees is responsible for the strategic management of the organisation and delivery of our charitable objectives.
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Autosomal recessive inheritance means that the faulty gene is on an autosome (any chromosome other than the sex chromosomes) and that both copies need to be faulty to cause sight loss
The following projects were being funded by Retina UK and have recently come to an end.
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.
Amar Latif is an adventurer, entrepreneur, TV presenter and public speaker. He became an Ambassador for Retina UK in 2020.